IDMC 15 MEETINg, 26-30 MAY, 2026, SAGUENAY, CANADA
ENTRY-DM was strongly represented at IDMC-15 (International Myotonic Dystrophy Consortium Meeting). For more information about ENTRY-DM contributions, please click on the links below:
Poster by DC8 Mireia Gromaz. Splicing modulation of DMPK EXON 15 as a therapeutic approach for Myotonic Dystrophy Type 1
https://zenodo.org/records/20717398
Poster by DC5 Sofia Gaspari. Focusing on foci: Expansion Microscopy for high-resolution characterization of repeat RNA-protein aggregates in DM
https://zenodo.org/records/20717534
Poster by DC3 Timothée Caboche. A Magnetic Actuator-Based Platform for Functional Assessment of 3D Human Skeletal Muscle Bioengineered Tissues in Myotonic Dystrophy
https://zenodo.org/records/20717652
Poster by DC9 Yasmine Ferchichi. Enhancing Antisense Oligonucleotide Activity in Myotonic Dystrophy Type 1 by Genetic and Chemical Modulation
https://zenodo.org/records/20717767
Poster by DCs 6 and 9 Angela Natividad i Mateu and Yasmine Ferchichi. Therapeutic Innovation, Clinical Trial Acceleration, and Lifestyle Interventions in Myotonic Dystrophy Type 1: A Systematic Review
https://zenodo.org/records/20717902
Poster by DC14 Maria Carolina F. A. OLIVEIRA. Cognitive and social decision-making skills in adult-onset Myotonic Dystrophy type 1 (DM1)
https://zenodo.org/records/20555232
Poster by DC13 Malin Larsen. Approaching Liquid Biopsy– A Comparative Overview of Current Biomarker Development in Myotonic Dystrophies
https://zenodo.org/records/20703731
Poster by DC12 Panagiotis Strevinas. Circulating Biomarkers of Brain Dysfunction in Myotonic Dystrophy type 1 (DM1)
https://zenodo.org/records/20718760
Poster by DC7 Anton Simoes. Patient-derived iPSC models suggest astrocytic involvement in DM1 neuropathology



